Janux Therapeutics
JANX
#6306
Rank
โ‚ฌ0.85 B
Marketcap
14,06ย โ‚ฌ
Share price
-1.29%
Change (1 day)
-36.72%
Change (1 year)

Revenue for Janux Therapeutics (JANX)

Revenue in 2026 (TTM): โ‚ฌ11.74 Million

According to Janux Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ12.02 Million. In 2025 the company made a revenue of โ‚ฌ8.51 Million a decrease over the revenue in the year 2024 that were of โ‚ฌ10.17 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Janux Therapeutics from 2020 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ11.74 M37.99%
2025 โ‚ฌ8.51 M-16.34%
2024 โ‚ฌ10.17 M39.15%
2023 โ‚ฌ7.31 M-8.93%
2022 โ‚ฌ8.02 M150%
2021 โ‚ฌ3.21 M
2020 N/A